Chicken Astrovirus

Overview and Taxonomy of Chicken Astrovirus

Chicken astrovirus (CAstV) represents a significant and increasingly recognized etiological agent within the global poultry industry, associated with a spectrum of economically devastating diseases including runting-stunting syndrome (RSS), severe kidney disease and visceral gout, and the emergent white chick syndrome (WCS) [6, 17, 24]. As a member of the family Astroviridae, genus Avastrovirus, CAstV is a non-enveloped, positive-sense, single-stranded RNA virus with a genome of approximately 7.0 to 7.5 kilobases (kb) in length, excluding the poly(A) tail [2, 4, 19]. The viral genome is organized into a canonical architecture comprising a 5′ untranslated region (UTR), three open reading frames (ORF1a, ORF1b, and ORF2), and a 3′ UTR that frequently harbors a conserved stem-loop II-like motif (s2m) [4, 11, 19]. ORF1a and ORF1b encode the non-structural polyproteins, including a serine protease and an RNA-dependent RNA polymerase (RdRp), respectively, while ORF2 encodes the structural capsid protein, the primary determinant of antigenicity, serotype specificity, and phylogenetic classification [6, 17, 20].

The taxonomic landscape of CAstV has undergone substantial revision since the virus was first formally recognized as a distinct species within the Avastrovirus genus in 2004, following its initial molecular characterization from cases of enteritis and poor growth in broiler flocks [6, 17]. Prior to this delineation, many historical isolates associated with avian nephritis, particularly those linked to the 1989 outbreak of baby chick nephropathy (BCN) in Japan, were retrospectively identified as CAstV rather than the previously suspected avian nephritis virus (ANV), underscoring the historical co-circulation and diagnostic confusion between these two closely related avastroviruses [14]. Indeed, genetic analysis of those archived Japanese strains confirmed their classification within CAstV subgroup Bi, demonstrating that the virus was present in poultry populations decades before its formal taxonomic recognition [14].

The current taxonomic framework for CAstV is based primarily on phylogenetic analysis of the complete ORF2 (capsid) amino acid sequence, which provides a robust and internationally accepted criterion for species demarcation and subgroup classification within the Avastrovirus genus [6, 20, 21]. This approach has resolved CAstV into two major genogroups, designated Group A and Group B, which are demarcated by a pairwise amino acid sequence identity of only 39% to 42% and a corresponding genetic p-distance of 0.59 to 0.62 [20]. This profound genetic divergence between the two genogroups is comparable to the distance observed between distinct astrovirus species, and some strains, such as the Polish isolate PL/G059/2014, exhibit such low ORF2 identity (32.7–35.2%) with other CAstVs that they have been proposed as candidates for a novel avastrovirus species [21]. Group A is further subdivided into three subgroups, Ai, Aii, and Aiii, with inter-subgroup amino acid identities ranging from 78% to 82% and intra-subgroup identities of 92% to 100% [20]. Group B, which encompasses the vast majority of globally circulating CAstV strains associated with clinical disease, has undergone a more dynamic expansion. Initially comprising four subgroups (Bi, Bii, Biii, and Biv), the classification has been progressively refined to include at least six recognized subgroups (Bi through Bvi), with inter-subgroup amino acid identities of 82% to 93% and intra-subgroup identities of 93% to 100% [11, 20]. The genetic p-distance within Group B subgroups ranges from 0.07 to 0.18, reflecting a continuum of diversity that complicates rigid demarcation [20].

The genetic diversity and evolutionary trajectory of CAstV are driven by two principal mechanisms: the accumulation of point mutations, particularly in the hypervariable spike region of the capsid protein, and recombination events that generate mosaic genomes [4, 12]. Recombination has been unequivocally demonstrated across multiple genomic regions, including ORF1a, ORF1b, and ORF2, and is considered a major force in the emergence of novel subgroups and antigenic variants [4, 12]. For instance, comprehensive recombination analyses of Canadian CAstV isolates from WCS outbreaks revealed multiple past recombination events that contributed to the substantial genetic variation observed among the seven antigenic sub-clusters now recognized within Group B [12]. Similarly, the Tanzanian CAstV strain was shown to harbor a 4,018-nucleotide recombinant fragment in the ORF1a/1b genomic region, derived from Eurasian CAstV-Bi and Bvi parental strains, illustrating the global interconnectedness of viral gene pools [4]. The Chinese isolate GD202013 was also identified as a recombinant, with a major parent from the United States and minor parents from the US and Poland, further emphasizing that recombination is a pervasive and ongoing process in CAstV evolution [7]. These recombination events, coupled with the high mutation rate inherent to RNA viruses, have facilitated the emergence of novel subgroups such as Bv, first described in Malaysian isolates that exhibited 86–91% ORF2 amino acid identity with established Group B strains, and Bvi, which has been associated with WCS in Brazil and North America [9, 11, 16]. The continuous discovery of new subgroups, including a proposed new B subgroup from China (JS202103), indicates that the current taxonomic framework is likely to require further expansion as global surveillance efforts intensify [5].

The epidemiological significance of this genetic diversity is profound. While all CAstV subgroups are enteric pathogens capable of causing subclinical to severe disease, specific subgroups have been disproportionately linked to particular clinical syndromes. Subgroup Biv, for example, has been consistently and strongly associated with WCS in Brazil, Canada, and the United States, with strains from these geographically disparate regions sharing greater than 95% amino acid identity in the capsid protein [9, 12, 16]. Subgroup Bii has been implicated in WCS outbreaks in Ontario, Canada, and in cases of severe kidney disease and visceral gout in China [10, 18]. Subgroup Bi strains have been recovered from hatchery disease in turkeys in Nigeria and from baby chick nephropathy in Japan, demonstrating the broad host range and pathogenic potential of this lineage [13, 14]. Importantly, the correlation between genotype and pathotype is not absolute; strains from multiple subgroups can induce similar clinical outcomes, and the severity of disease is modulated by factors such as viral load, co-infection with other enteric pathogens (notably ANV, avian rotavirus, and chicken parvovirus), route of transmission (horizontal versus vertical), and the age and immune status of the host [1, 3, 6, 17, 22]. The high prevalence of CAstV in commercial poultry, detected in 53% of chickens with enteritis in Ecuador, 61% of flocks in Austria, and 55.6% of clinical samples in southern China, underscores its ubiquitous nature and the critical need for refined taxonomic tools to inform vaccine development and disease control strategies [1, 5, 23]. The World Organisation for Animal Health (WOAH) recognizes the economic threat posed by avian astroviruses, and the Food and Agriculture Organization (FAO) has highlighted the importance of surveillance for emerging enteric viruses in poultry production systems to safeguard global food security. The ongoing molecular characterization of CAstV isolates from diverse geographic regions, including recent first reports from Ecuador, Bangladesh, Tanzania, and Malaysia, continues to reshape our understanding of its taxonomy and global phylodynamics [1, 2, 4, 8, 15].

Genomic Organization and Replication of Chicken Astrovirus

Genome Architecture and Structural Features

Chicken astrovirus (CAstV) possesses a positive-sense, single-stranded RNA genome that exhibits the canonical architecture characteristic of the family Astroviridae. The complete genome length typically ranges from approximately 6,918 to 7,513 nucleotides, excluding the poly(A) tail, a size range that has been consistently documented across multiple global isolates [4, 10, 19]. The genomic organization follows the conserved avastrovirus blueprint: 5′-untranslated region (UTR)–open reading frame 1a (ORF1a)–ORF1b–ORF2–3′-UTR [4]. This tripartite ORF structure is a defining feature of the genus Avastrovirus, with ORF1a and ORF1b encoding the nonstructural polyproteins involved in viral replication and proteolytic processing, while ORF2 encodes the structural capsid protein responsible for virion assembly, host cell attachment, and immune recognition.

The 5′ UTR of CAstV is notably compact, with the Indian isolate CAstV/INDIA/ANAND/2016 possessing only 13 nucleotides preceding the translation start site [19]. This brevity is a common feature among avastroviruses and likely facilitates efficient ribosome scanning and translation initiation. At the opposite terminus, the 3′ UTR is considerably more complex and functionally significant. In the Indian isolate, the 3′ UTR extends to 298 nucleotides and harbors two highly conserved stem-loop II-like motifs (s2m), an RNA structural element of profound biological importance [19]. The s2m motif is a remarkably conserved 43-nucleotide RNA structure that has been identified not only in astroviruses but also in coronaviruses, picornaviruses, and other RNA virus families. Its presence in the 3′ UTR of CAstV suggests a critical, albeit incompletely understood, role in viral RNA replication, translational regulation, or packaging. The genome terminates in a poly(A) tail, typically 19–20 nucleotides in length, which is essential for mRNA stability and translation initiation [19]. This polyadenylated structure, combined with the 5′ cap (presumed but not definitively demonstrated in all isolates), renders the CAstV genome functionally analogous to cellular mRNAs, allowing it to hijack the host translational machinery immediately upon entry.

Open Reading Frame 1a and 1b: The Replicase Complex

ORF1a encodes a large polyprotein containing a serine protease domain, which is responsible for the proteolytic cleavage of the viral polyprotein into functional subunits [19]. The serine protease activity is essential for processing the nonstructural proteins that orchestrate the assembly of the replication complex. Comparative genomic analyses have revealed that ORF1a exhibits substantial sequence diversity across CAstV strains, with nonsynonymous mutations accumulating over time and contributing to the emergence of variant strains. Bi et al. (2023) demonstrated that amino acid mutations in ORF1a, along with changes in ORF1b and ORF2, were pivotal in the emergence of a novel CAstV variant associated with proventriculitis and pancreatitis in China [27]. This finding underscores the functional plasticity of the replicase proteins and their capacity to accommodate genetic variation without catastrophic loss of function.

ORF1b encodes the RNA-dependent RNA polymerase (RdRp), the catalytic core of the viral replication complex [19]. The RdRp is responsible for both genome replication and transcription of subgenomic RNA, and its activity is absolutely required for viral propagation. The expression of ORF1b is achieved through a -1 ribosomal frameshift mechanism, a strategy common to many positive-sense RNA viruses. During translation of the ORF1a-ORF1b polyprotein, a slippery sequence and a downstream RNA pseudoknot induce a proportion of ribosomes to shift reading frame, thereby producing a fusion protein containing both ORF1a and ORF1b sequences. This elegant translational recoding mechanism ensures the production of the RdRp at a stoichiometry appropriate for replication. The ORF1b gene, being relatively conserved across CAstV strains due to functional constraints on the RdRp, has been widely used as a target for molecular diagnostics, including the RT-qPCR and SYBR Green-based assays described by Santander-Parra et al. (2025) and Loor-Giler et al. (2025) [1, 2].

Open Reading Frame 2: The Capsid Protein and Genetic Diversity

ORF2 encodes the capsid precursor protein, which is the most genetically variable region of the CAstV genome and the primary determinant of antigenic diversity and serotype classification. The capsid protein is responsible for receptor binding, host cell entry, and elicitation of the host immune response. Phylogenetic analyses based on complete ORF2 amino acid sequences have revealed a bipartite classification system dividing CAstV into two major genogroups, designated A and B, with multiple subgroups within each genogroup [5, 20]. Group A comprises three subgroups (Ai, Aii, and Aiii), while Group B has expanded to include at least six subgroups (Bi, Bii, Biii, Biv, Bv, and Bvi), reflecting the remarkable ongoing diversification of this virus [5, 20, 21].

The inter-group amino acid identity between Group A and Group B CAstVs is profoundly low, ranging from 37.01% to 40.52%, a finding that initially led some investigators to propose that certain strains, such as the Polish isolate PL/G059/2014, might warrant classification as a separate species within the genus Avastrovirus [9, 21]. Within Group B, the inter-subgroup amino acid identity ranges from 82% to 93%, while intra-subgroup identity exceeds 93%, often reaching 95–100% [20]. This hierarchical genetic structure indicates that capsid sequence divergence is the primary driver of CAstV evolution and that recombination events frequently occur within and between subgroups, further complicating the taxonomic landscape.

The capsid protein contains a highly variable spike region that protrudes from the virion surface and is the primary target of neutralizing antibodies. Kariithi et al. (2023) identified numerous amino acid variations, including substitutions, insertions, and deletions, specifically within the spike region of CAstV and avian nephritis virus (ANV) strains from Tanzanian live bird markets [4]. These variations have direct implications for antigenic drift, vaccine design, and serological diagnostic accuracy. Indeed, the failure of enzyme-linked immunosorbent assays (ELISA) to detect antibodies in vaccinated birds, as reported by Sousa et al. (2025), while virus neutralization assays using genetically matched antigens succeeded, highlights the critical importance of capsid sequence matching for effective serological monitoring [25].

Genomic Recombination as a Driving Force in Evolution

Recombination is a major evolutionary force shaping the genetic landscape of CAstV, and multiple independent studies have provided compelling evidence for its prevalence. Palomino-Tapia et al. (2020) performed a comprehensive recombination analysis using RDP5 and SimPlot software on 14 complete genome sequences from white chick syndrome (WCS) outbreaks in Western Canada, spanning 2014–2019. Their analyses revealed multiple past recombination events distributed across ORF1a, ORF1b, and ORF2, suggesting that recombination, combined with the accumulation of point mutations, has contributed substantially to the genetic variation observed in CAstV and the emergence of seven antigenic sub-clusters [12].

Yin et al. (2021) identified the Chinese isolate GD202013 as a recombinant strain formed by three parental strains: a major parent (CkP5/US/2016) and two minor parents (GA2011/US/2011 and G059/PL/2014) [7]. This tripartite recombination event underscores the complexity of CAstV evolution and the capacity of the virus to generate novel genotypes through RNA template switching during replication. Kariithi et al. (2023) further demonstrated that a CAstV-A strain from Tanzania possessed a 4,018-nucleotide recombinant fragment spanning the ORF1a/1b genomic region, with predicted parental strains from Eurasian CAstV-Bi and Bvi subgroups [4]. This finding is particularly significant because it documents inter-subgroup recombination, a phenomenon that can dramatically alter the genetic and antigenic properties of the virus, facilitating host immune evasion and potentially altering tissue tropism and pathogenicity.

The high frequency of recombination in CAstV is facilitated by its single-stranded positive-sense RNA genome, the presence of co-infections with multiple strains in the same host, and the error-prone nature of the RdRp, which generates a diverse pool of viral RNAs available for template switching. Co-infections are exceedingly common in commercial poultry, as documented by Loor-Giler et al. (2025), who found that 97% of 200 chickens tested were positive for at least one enteric virus, with CAstV and ANV co-infections being particularly prevalent [1]. These mixed infections provide the ideal substrate for recombination, which is a key mechanism for generating the genetic diversity that enables CAstV to adapt to new hosts, evade immune responses, and cause a spectrum of clinical diseases ranging from enteritis to systemic gout and white chick syndrome.

Replication Strategy and Host-Virus Interactions

The replication cycle of CAstV begins with the attachment of the capsid protein to host cell receptors, followed by receptor-mediated endocytosis and release of the genomic RNA into the cytoplasm. As a positive-sense RNA virus, the genomic RNA is immediately translated by host ribosomes to produce the viral polyproteins. The ORF1a-ORF1b polyprotein is processed by the viral serine protease to generate the mature nonstructural proteins, including the RdRp, which then initiates genome replication. The RdRp synthesizes a full-length negative-sense RNA intermediate, which serves as a template for the production of both new genomic RNAs and a subgenomic RNA (sgRNA) that is used for the translation of the capsid protein from ORF2.

Recent work by Zhou et al. (2025) has uncovered a sophisticated strategy employed by CAstV to protect its viral RNA from degradation by host cytoplasmic ribonucleases. They demonstrated that CAstV, along with other positive-sense RNA viruses, hijacks the host cellular protein Musashi homolog 1 (MSI1). Upon infection, CAstV upregulates MSI1 expression and facilitates its translocation from the cytoplasmic periphery to a position proximal to and within the nucleus. The viral genome, through specific regions including the unique region or the 3′ UTR, engages with MSI1, thereby shielding the viral RNA from degradation by cytoplasmic RNases [28]. This discovery reveals a previously unrecognized layer of host-virus interaction that is critical for the establishment of productive infection and offers potential targets for antiviral intervention.

The replication of CAstV is intimately linked to the host cell's RNA metabolism and stress responses. Sajewicz-Krukowska et al. (2023) profiled miRNA expression in CAstV-infected chickens using next-generation sequencing and identified 58 mature miRNAs that were significantly differentially expressed. These miRNAs targeted 4,741 genes, with gene ontology and KEGG pathway enrichment analyses revealing involvement in the regulation of cellular processes and immune responses [26]. The modulation of the host miRNA landscape by CAstV represents a sophisticated viral strategy to create a cellular environment permissive for replication while subverting antiviral defenses. The interplay between viral replication, host miRNA regulation, and the MSI1-mediated RNA protection mechanism highlights the complex molecular tug-of-war that defines the CAstV replication cycle.

Molecular Pathogenesis of Chicken Astrovirus

The molecular pathogenesis of chicken astrovirus (CAstV) represents a complex, multifactorial process that is only beginning to be elucidated despite the virus’s significant global economic impact on poultry production. As a member of the genus Avastrovirus within the family Astroviridae, CAstV is a non-enveloped, positive-sense, single-stranded RNA virus with a genome of approximately 7.0–7.5 kb [2, 4, 19]. The canonical genome architecture comprises a 5′ untranslated region (UTR), three open reading frames (ORF1a, ORF1b, and ORF2), and a 3′ UTR terminating in a poly(A) tail [4, 19]. ORF1a encodes a serine protease and other non-structural proteins involved in polyprotein processing, ORF1b encodes the RNA-dependent RNA polymerase (RdRp) essential for genome replication, and ORF2 encodes the capsid precursor protein, which is cleaved into the mature structural proteins that determine antigenicity, host cell tropism, and immune evasion [6, 17, 20]. The intricate interplay between these viral components and the host cellular machinery dictates the spectrum of clinical outcomes, ranging from subclinical enteric infection to severe systemic disease, including runting-stunting syndrome (RSS), severe kidney disease with visceral gout, and the vertically transmitted white chick syndrome (WCS) [6, 17, 24].

Genomic Determinants of Pathogenicity and Tissue Tropism

The capsid protein, encoded by ORF2, is the primary determinant of serotype, genetic diversity, and, critically, tissue tropism and pathogenicity. Phylogenetic analyses based on the complete ORF2 amino acid sequence have robustly demarcated CAstV into two major genogroups (A and B), with group B further subdivided into at least six subgroups (Bi through Bvi) [5, 20]. The inter-group amino acid identity is remarkably low, at only 39–42%, while intra-subgroup identities can exceed 95% [9, 20]. This extreme genetic variability in the capsid, particularly within the hypervariable spike domain, directly influences the virus’s ability to infect different cell types and evade host immune responses. For instance, strains associated with WCS and severe kidney disease (visceral gout) predominantly cluster within group B, specifically subgroups Bii, Biv, and Bv, suggesting that specific capsid conformations confer the ability to replicate efficiently in renal and hepatic tissues [9, 12, 18, 24]. The Brazilian Biv strains, for example, share >95% amino acid identity with North American WCS-associated strains, reinforcing a conserved molecular signature for this pathogenic phenotype [9, 16]. Conversely, strains causing primarily enteric disease (RSS) are more broadly distributed across both genogroups, indicating that enteric tropism is a more ancestral or conserved trait [17, 20].

Recombination is a major driving force in CAstV evolution and the emergence of novel pathogenic variants. Multiple recombination events have been identified across the genome, particularly within the ORF1a/ORF1b region and the ORF2 capsid gene [4, 7, 12]. Analysis of Canadian WCS isolates revealed that recombination between different parental strains (e.g., CAstV-Bi and Bvi) has generated chimeric viruses with altered pathogenic potential [12]. Similarly, the Chinese isolate GD202013 was demonstrated to be a recombinant of US and Polish strains, acquiring a unique genomic configuration that facilitated its emergence in a new geographic region [7]. The Tanzanian CAstV-A strain also harbors a large recombinant fragment in the ORF1a/1b region, predicted to originate from Eurasian B-group viruses, illustrating how recombination can blur the lines between genogroups and generate viruses with expanded host ranges or enhanced virulence [4]. These recombination events, combined with the accumulation of point mutations, particularly in the capsid spike region, allow CAstV to continuously generate antigenic diversity, complicating vaccine development and diagnostic surveillance [5, 12, 20].

Molecular Mechanisms of Cellular Entry and Replication

The initial steps of CAstV infection involve the interaction of the capsid spike domain with unidentified host cell receptors on the apical surface of enterocytes, and potentially renal tubular epithelial cells and hepatocytes. The presence of a conserved stem-loop II-like motif (s2m) in the 3′ UTR of some CAstV strains, including Malaysian Bv isolates, is hypothesized to play a role in RNA replication, translation, or packaging, though its exact function in pathogenesis remains to be fully defined [11, 19]. Following receptor-mediated endocytosis, the viral genome is released into the cytoplasm, where it serves as a template for translation of the ORF1a-ORF1b polyprotein. The viral serine protease encoded by ORF1a cleaves this polyprotein into functional non-structural proteins, including the RdRp, which then synthesizes a negative-sense RNA intermediate. This intermediate serves as a template for the production of genomic and subgenomic RNAs, the latter of which directs the translation of the capsid protein [6, 19].

A critical, recently elucidated aspect of CAstV replication is its ability to hijack host cellular proteins to evade innate antiviral defenses. A landmark study demonstrated that CAstV, along with other positive-strand RNA viruses, upregulates the expression of host Musashi homolog 1 (MSI1) and facilitates its translocation from the cytoplasm to a perinuclear and intranuclear location [28]. This hijacking of MSI1 is mediated by specific regions of the viral genome, including the 3′ UTR. Once relocalized, MSI1 binds to the viral RNA, effectively shielding it from degradation by cytoplasmic ribonucleases [28]. This represents a sophisticated viral strategy to ensure the stability and persistence of viral RNA during replication, directly contributing to the efficiency of viral propagation and the severity of infection. The ability to subvert this fundamental host defense mechanism is likely a key determinant of CAstV’s success as a pathogen.

Host-Virus Interactions and Immunopathogenesis

The host immune response to CAstV infection is a double-edged sword, capable of both controlling viral replication and contributing to tissue pathology. In naturally occurring WCS cases, infection is characterized by a robust but ultimately ineffective innate immune response. Transcriptional profiling of tissues from affected chicks reveals significant upregulation of T helper 1 (Th1) and Th2 cytokines, including interferon-gamma (IFN-γ), interleukin-2 (IL-2), IL-8, IL-12p40, IL-15, transforming growth factor-beta 4 (TGF-β4), and tumor necrosis factor superfamily 15 (TNF-SF-15), along with the transcription factor T-bet [16]. This cytokine storm, particularly in the jejunum, is indicative of a strong pro-inflammatory response. However, despite this activation, the immune system fails to control viral replication, as evidenced by the high viral loads detected in the gut and other organs [16]. This suggests that CAstV possesses potent mechanisms to antagonize the antiviral effects of IFN-γ and other cytokines, allowing it to replicate unabated. The resulting inflammation, while ineffective at clearing the virus, likely contributes to the intestinal damage, villous atrophy, and malabsorption characteristic of RSS and enteric disease [29, 31].

The role of microRNAs (miRNAs) in regulating the host response to CAstV is an emerging area of research. Infection induces a significant differential expression of host miRNAs, which in turn regulate a vast network of target genes involved in cellular processes and immune signaling pathways [26]. These miRNA-mediated changes can fine-tune the expression of pro- and anti-inflammatory factors, potentially influencing the balance between viral clearance and immunopathology. The specific miRNA signatures induced by CAstV infection may also serve as biomarkers for disease severity or predictors of clinical outcome.

Pathogenesis of Specific Disease Syndromes

The molecular pathogenesis of CAstV is best understood in the context of the specific disease syndromes it causes. In RSS and enteric disease, the virus primarily targets the intestinal epithelium, leading to villous atrophy, crypt hyperplasia, and fusion of villi, which results in malabsorption, diarrhea, and poor growth [29, 31]. Co-infections with other enteric viruses, such as avian nephritis virus (ANV), avian rotavirus, and chicken parvovirus, are extremely common and exacerbate the clinical severity, likely through synergistic effects on gut barrier disruption and immune modulation [1, 3, 22, 23]. The high prevalence of CAstV in hatchery and day-old chick samples, coupled with its detection in yolk sacs, confirms that vertical transmission is a critical route for introducing the virus into naive flocks, leading to early-onset disease [2, 3, 30].

In severe kidney disease and visceral gout, the pathogenesis shifts to a systemic infection. CAstV strains with specific capsid genotypes (e.g., Bii, Biv) demonstrate a tropism for renal tubular epithelial cells. Viral replication in the kidney leads to tubular necrosis and interstitial nephritis, impairing the organ’s ability to excrete uric acid [10, 11, 27, 32]. The resulting hyperuricemia leads to the deposition of urate crystals on the viscera (visceral gout), epicardium, and in the joints. Biochemical analyses confirm significant elevations in serum uric acid (UA), blood urea nitrogen (BUN), and liver enzymes (AST, ALT), indicating concurrent hepato-renal damage [27, 33]. The molecular basis for this renal tropism is likely encoded within the capsid spike domain, which may interact with specific receptors on kidney cells that are absent or less abundant on enterocytes.

White chick syndrome (WCS) represents the most severe manifestation of vertical transmission. The virus infects the developing embryo, causing profound growth retardation, hepatomegaly, and characteristic pale down [9, 18, 24, 30]. The molecular pathogenesis involves widespread viral replication in multiple embryonic tissues, including the liver, kidney, and yolk sac, leading to metabolic dysfunction and failure to thrive [16, 30]. The high viral load in the liver is associated with necrotic hepatitis, while renal damage contributes to the edema and ascites often observed in affected chicks [16, 18]. The capsid protein of WCS-associated strains (Biv, Bii) contains specific antigenic peptides predicted to be highly immunogenic, and the inability of the immature embryonic immune system to mount an effective response likely contributes to the high mortality [9, 16]. The transient nature of WCS outbreaks in breeder flocks, with recovery occurring as hens seroconvert, underscores the critical role of maternal antibodies in protecting progeny [24, 25].

In summary, the molecular pathogenesis of CAstV is a dynamic interplay between a genetically plastic virus and its host. The virus leverages recombination and point mutation to generate capsid diversity, enabling it to target different tissues and evade immune pressure. It employs sophisticated strategies, such as hijacking MSI1, to protect its RNA from degradation, and it induces a dysregulated immune response that contributes to tissue damage. The specific clinical outcome, be it enteric disease, nephritis, or WCS, is determined by the complex interaction of viral genotype, host age and immune status, route of transmission, and the presence of co-infecting pathogens. Understanding these molecular mechanisms at a granular level is essential for the rational design of effective vaccines and antiviral strategies to mitigate the substantial economic losses caused by this ubiquitous avian pathogen.

Epidemiology and Transmission Dynamics

Chicken astrovirus (CAstV) has emerged as a globally pervasive pathogen of considerable economic significance to the poultry industry, demonstrating a remarkable capacity for dissemination across diverse production systems and geographic regions. The epidemiological landscape of CAstV is characterized by its high prevalence in commercial flocks, intricate patterns of co-infection with other enteric viruses, and a dual transmission strategy that encompasses both horizontal and vertical pathways, enabling its persistence and rapid spread. Understanding these dynamics is critical for the development of effective control measures, particularly given the absence of commercially available vaccines and the virus's association with syndromes such as runting-stunting syndrome (RSS), severe kidney disease, visceral gout, and white chick syndrome (WCS) [6, 17, 24, 32].

Global Distribution and Prevalence

The ubiquitous nature of CAstV is underscored by its detection across all continents with intensive poultry production, including North and South America, Europe, Asia, Africa, and Oceania. Prevalence rates vary considerably depending on the diagnostic methodology employed (conventional RT-PCR vs. RT-qPCR), the age of the birds sampled, the clinical status of the flock, and the sampled tissue type. Nevertheless, a consistent pattern emerges: CAstV is one of the most frequently detected enteric viruses in chickens worldwide.

In a comprehensive survey of 200 broiler chickens with enteric disease in Ecuador, a highly sensitive multiplex RT-qPCR assay detected CAstV in 53% of samples, second only to avian nephritis virus (ANV) at 89% [1]. A companion study using SYBR Green-based RT-qPCR on 120 jejunal samples from seven-day-old chicks in Ecuador reported an even higher detection rate of 70.8% (85/120), with mean viral loads reaching 9.6 × 10⁶ gene copies, indicating active replication and significant viral burdens in young birds [2]. These findings from South America are mirrored in other regions. In Austria, a longitudinal study of clinically healthy broiler flocks over two production cycles found CAstV in 61% of sampled flocks via RT-PCR, demonstrating that the virus circulates even in the absence of overt clinical disease, a point of considerable epidemiological importance [23]. Similarly, in a survey of 34 Korean broiler flocks with a history of enteritis, CAstV was identified in 38.2% of flocks, making it the second most prevalent enteric virus after ANV (44.1%) [22].

Data from Brazil, a major global poultry producer, reinforces the high prevalence of CAstV. Analysis of 270 samples collected from eleven Brazilian states between 2010 and 2017 revealed that CAstV was among the most common enteric viruses detected, alongside fowl adenovirus group I and chicken parvovirus [37]. The virus has been specifically implicated in Brazilian outbreaks of WCS since at least 2015, with molecular characterization of the capsid (ORF2) gene consistently placing Brazilian isolates within subgroup Biv [9, 16, 30]. Phylogenetic analyses of these Brazilian strains show high nucleotide identity (75.7–80.6%) and amino acid similarity (84.2–89.9%) with other group B members, confirming the clonal expansion of this subgroup in the region [16].

In Asia, CAstV prevalence is equally notable. In China, a large-scale surveillance effort across six provinces from 2020 to 2022 detected CAstV in a significant proportion of clinical samples, with 82.5% positivity reported in one study of 154 samples from “yellow” chickens exhibiting poor performance [35]. A separate investigation of 36 clinical samples from Guangdong province found a prevalence of 55.6%, with the virus detected as a sole pathogen after excluding other common enteric agents [7]. In India, the first molecular detection of CAstV from Kerala state was documented in five of 50 broiler flocks (10%) exhibiting retarded growth and diarrhea, with isolates showing up to 100% nucleotide identity with other Indian strains [34]. A broader study in India examining 604 birds from commercial farms with enteritis reported an overall CAstV prevalence of 20.52%, with the highest rate (49.29%) observed in chicks aged 0–1 week, strongly implicating vertical transmission as a major source of early exposure [29]. In Bangladesh, the first confirmed report of CAstV detected the virus in 25.8% of sampled flocks (8/31), with mixed infections of CAstV and ANV occurring in an additional 19.3% of flocks [15]. A Malaysian study identified 20 CAstV-positive samples from broiler flocks with uneven growth, and serological testing of broiler breeder flocks revealed a high prevalence of anti-CAstV antibodies, indicating widespread exposure within the national breeder population [8]. Recently, a novel CAstV isolate from Malaysia was assigned to a new subgroup, Bv, based on ORF-2 capsid sequence analysis (86–91% identity with other group B viruses), expanding the known genetic diversity of the virus in Southeast Asia [11].

In Africa, serological and molecular evidence confirms the presence of CAstV. A study in Grenada, West Indies, detected anti-CAstV antibodies in 61.5% of indigenous chickens and 57.6% of commercial layers, demonstrating widespread exposure across the island [36]. In Nigeria, a survey of day-old commercial turkey poults condemned at hatcheries revealed an alarming 83.5% positivity for CAstV by RT-PCR, while all samples were negative for other tested enteric viruses (avian rotavirus, reovirus, fowl adenovirus, and parvovirus). This suggests CAstV is a primary causative agent of hatchery disease in turkeys in that region, and highlights a potential cross-species transmission risk [13].

Transmission Dynamics: A Dual-Mode Strategy

The perpetuation of CAstV within and between poultry populations is facilitated by two fundamentally distinct but synergistic transmission modes: horizontal transmission via the fecal–oral route, and vertical transmission through the egg.

Horizontal Transmission and Environmental Persistence. Horizontal transmission is the primary mechanism for the rapid dissemination of CAstV within a flock. Infected birds shed large quantities of virus in their feces, with viral loads reaching up to log₁₀ 13.23 copies per cloacal swab at 3 days post-infection (dpi) in experimental settings [11]. This fecal material contaminates the litter, feed, water, and fomites within the poultry house. The virus is a non-enveloped, single-stranded RNA virion, a structural feature that confers considerable environmental stability, allowing it to persist in organic matter and on surfaces for extended periods. The detection of CAstV in hatchery environmental samples is inconsistent, one Italian study found it absent from hatchery surfaces and eggshells while present in chick tissues [3], but its presence in litter from infected breeder farms is a known risk factor. Movement of contaminated litter from seropositive to seronegative farms has been used as a deliberate exposure strategy to induce immunity in replacement pullets before they enter lay, although this practice carries the risk of introducing other pathogens like Salmonella [25]. A study on Austrian broiler farms directly correlated the prevalence of CAstV with biosecurity practices: flocks raised on farms that utilized barn-specific clothing, footbaths, and regular vermin control had significantly lower CAstV prevalence, confirming the importance of mechanical vectors and fomites in viral spread [23].

Vertical Transmission: The Key to Early Infection and Hatchery Disease. The most epidemiologically consequential aspect of CAstV transmission is its ability to be vertically transmitted from infected broiler breeders to their progeny. This mechanism explains the detection of the virus in day-old chicks, unhatched embryos, and its central role in hatchery-associated diseases such as WCS. The first Italian study to follow astrovirus dynamics from hatchery to farm provided direct evidence of this pathway: CAstV RNA was detected in the yolk sacs of embryonated eggs at 18 days of incubation, and in the gut contents of one-day-old chicks, while the embryos themselves and the eggs' external surfaces were negative [3]. This strongly suggests that the virus is present within the egg before oviposition, likely introduced via the reproductive tract of the hen.

The link between vertical transmission and WCS is particularly well-documented. WCS is characterized by a sudden drop in hatchability over a 2–3 week period, an increase in mid-to-late embryo mortality, and the hatching of weak, pale chicks with enlarged abdomens and characteristic liver pathology [9, 18, 24]. The condition is temporally associated with seroconversion in the breeder flock: once hens develop immunity to CAstV (typically after 2–3 weeks), hatchability returns to normal, and progeny are protected by maternally derived antibodies [24]. In a Canadian study of WCS outbreaks in Ontario (2009–2016), affected broiler breeder flocks experienced hatchability drops of 0% to 68.4%, and all affected embryos and chicks were positive for CAstV RNA, with capsid sequencing revealing all Ontario strains belonged to subgroup Bii [18]. Brazilian studies have similarly linked WCS to CAstV subgroup Biv, with the virus detected in the yolk sac, serum, spleen, thymus, and jejunum of affected chicks, confirming systemic infection acquired prior to hatching [16, 30]. The virus's ability to reach the reproductive tract of laying hens is further supported by its detection in the ovaries and oviduct tissue of seropositive breeders, though detailed mechanistic studies are lacking.

Vertical transmission is not limited to WCS-causing strains. In China, a novel variant CAstV (SDAU2022) isolated from a small-scale broiler farm with growth retardation and 3% mortality was shown to cause viremia and viral shedding by 3 dpi in experimentally infected chickens, with the highest viral loads in the proventriculus, liver, kidney, duodenum, and pancreas [27]. The presence of the virus in the liver and kidney of these birds at very early time points post-hatch (3 dpi) is consistent with infection having occurred via the vertical route.

Age-Related Susceptibility and Co-infection Dynamics

Epidemiological data consistently indicate that CAstV infection is most prevalent and clinically significant in very young birds, particularly in the first week of life. The Indian study cited above found that nearly half of all CAstV detections occurred in chicks less than one week old [29]. Similarly, in Brazil, CAstV was most frequently detected in young broilers (under 3 weeks of age), in contrast to infectious bronchitis virus, which was more common in older hens [37]. This age-related pattern reflects the combined effect of vertical transmission (which exposes chicks at the point of hatch) and the immaturity of the neonatal immune system, which is less capable of controlling viral replication. The innate immune response in CAstV-infected day-old chicks is characterized by the activation of multiple Th1 and Th2 cytokines (IFN-γ, IL-2, IL-8, IL-12p40, IL-15, TGF-β4, TNF-SF-15, and t-BET) without effectively curbing viral replication, particularly in the gut [16]. This suggests an over-exuberant but poorly directed host response contributes to pathology in very young birds.

CAstV almost never circulates in isolation in the field. Co-infections are the rule rather than the exception, complicating efforts to attribute specific clinical outcomes to CAstV alone. The Ecuadorian study [1] found that 97% of chickens were positive for at least one of five enteric viruses, and co-infections between CAstV and ANV were the most common combination. In Austria, individual flocks were infected with up to five different enteric viruses simultaneously, and the number of viruses detected was statistically associated with poorer weight gain and higher mortality, regardless of the presence of clinical diarrhea [23]. In Korea, diverse combinations of CAstV, ANV, chicken parvovirus, IBV, avian reovirus, and avian rotavirus were detected in over half of enteritis-affected flocks [22]. This polymicrobial nature of enteric disease in poultry aligns with the “Fieldstone” hypothesis, where subclinical infections with multiple agents collectively impair intestinal function, leading to malabsorption, stunting, and increased feed conversion ratios. The epidemiological significance of this is that CAstV's pathogenic impact is often synergistic, not independent.

Molecular Epidemiology and Genetic Diversity

A comprehensive understanding of CAstV transmission dynamics requires appreciation of its substantial genetic diversity. CAstV is classified into two genogroups, A and B, based on the amino acid sequence of the capsid (ORF2) protein, with genogroup A exhibiting 39–42% identity with genogroup B at the amino acid level [20]. Within genogroup A, three subgroups (Ai, Aii, Aiii) have been identified, while genogroup B has expanded to at least six subgroups (Bi through Bvi), with inter-subgroup amino acid identities ranging from 82% to 93% [20]. This classification, while phylogenetically robust, does not correlate with specific clinical syndromes; strains from multiple subgroups have been associated with RSS, WCS, and kidney disease.

The genetic diversity of CAstV is driven by two primary evolutionary forces: the accumulation of point mutations in the RNA-dependent RNA polymerase (RdRp) gene, which lacks proofreading activity, and recombination events between co-infecting strains. The first comprehensive analysis of recombination in CAstV was performed on 14 whole-genome sequences from WCS outbreaks in Western Canada, which all belonged to the novel Biv subgroup. Recombination detection software (RDP5 and SimPlot) revealed multiple past recombination events within ORF1a, ORF1b, and ORF2, suggesting that these events, combined with point mutations, have driven the emergence of the seven antigenic sub-clusters now recognized [12]. A Tanzanian CAstV strain was found to contain a 4018-nucleotide recombinant fragment in the ORF1a/1b region, derived from putative Eurasian CAstV-Bi and Bvi parental strains, providing evidence for intercontinental recombination [4]. Similarly, the Chinese isolate GD202013 is a recombinant of major parent CkP5/US/2016 and minor parents GA2011/US/2011 and G059/PL/2014 [7]. These findings indicate that CAstV populations are highly dynamic, with recombination generating novel chimeric viruses that may exhibit altered tissue tropism, transmission efficiency, or antigenicity.

The World Organisation for Animal Health (WOAH) recognizes the economic impact of enteric viruses in poultry, though CAstV is not currently listed as a notifiable pathogen. However, its high prevalence, vertical transmission, and association with production losses across multiple continents make it a target for surveillance under the FAO’s One Health approach to food security. The continued emergence of novel subgroups (e.g., Bv in Malaysia, Bvi in Brazil) and the detection of ancestral strains in historical samples, such as the retrospective identification of CAstV in Japanese baby chick nephropathy cases from 1989, 15 years before the virus’s formal recognition [14], underscore the need for ongoing molecular epidemiological surveillance to inform vaccine development and control strategies.

Clinical Syndromes: White Chick Syndrome and Enteric Disease

Chicken astrovirus (CAstV) is now recognized as a pathogen of considerable economic consequence in global poultry production, associated with two overlapping but clinically distinct disease manifestations: white chick syndrome (WCS) and enteric disease, the latter often manifesting as runting-stunting syndrome (RSS). The profound impact of these conditions, including reduced hatchability, increased embryo mortality, growth retardation, and poor flock uniformity, has driven intensive investigation into the pathogenic mechanisms and epidemiological patterns that differentiate these syndromes [6, 17, 24]. Critically, the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have underscored the need for enhanced surveillance of emerging avian viral diseases, given their potential to disrupt food security and international trade in poultry products. The clinical syndromes associated with CAstV infection represent a complex interplay between viral genetic diversity, host age and immune status, route of transmission, and the presence of concomitant pathogens. Understanding this interplay is essential for developing rational control strategies, as the same virus can produce vastly different outcomes depending on the context of infection.

White Chick Syndrome: Clinical Presentation and Pathological Hallmarks

White chick syndrome is a vertically transmitted hatchery disease that has emerged as a major cause of economic loss in broiler breeder operations worldwide. The syndrome was first described in the context of astrovirus infection in the early 2000s, though retrospective genetic analyses have revealed that CAstV strains associated with WCS were circulating decades earlier, as evidenced by the reclassification of Japanese baby chick nephropathy isolates from 1989 as CAstV subgroup Bi [14, 17]. The clinical presentation of WCS is striking and unmistakable. Affected chicks at hatch are typically weak, lethargic, and exhibit pale to white down feathers, a feature that gives the syndrome its name. These chicks often present with distended abdomens, and a significant proportion will have brown, wiry fluff on the dorsum of the neck [18]. Mortality among affected hatchlings is high, and survivors frequently fail to thrive.

The pathological basis of WCS is rooted in the virus’s tropism for the liver and its capacity to disrupt hepatic function during embryonic development. Gross necropsy findings in affected embryos and day-old chicks consistently reveal hepatomegaly with pallor and friability, often accompanied by intestinal distension with liquid and gaseous contents [18, 30]. Histologically, the liver exhibits multifocal necrotic hepatitis, characterized by hepatocellular vacuolation, loss of architectural integrity, and infiltration of inflammatory cells [16, 18]. Critically, CAstV RNA has been detected in virtually every organ system of WCS-affected chicks, including the brain, thymus, spleen, kidney, and yolk sac, confirming that the infection is systemic and not confined to the enteric tract [30]. This widespread tissue distribution underscores the capacity of vertically transmitted CAstV strains to establish a disseminated infection in the developing embryo, with the liver serving as a primary target organ for virus-induced damage. The hepatic lesions likely contribute to metabolic derangements that manifest as the characteristic white plumage, poor growth, and high early mortality.

The viral load dynamics within affected tissues provide additional insight into pathogenesis. In naturally infected WCS chicks, the jejunum consistently harbors the highest concentration of viral RNA, yet this organ often lacks significant microscopical alterations, whereas necrotic hepatitis is prominent [16]. This paradox suggests that the pathogenesis of WCS involves both direct viral cytopathology in the liver and indirect effects mediated by the host immune response, including the activation of Th1 and Th2 cytokine pathways. Upregulation of interferon-gamma (IFN-γ), interleukin-2 (IL-2), IL-8, IL-12p40, IL-15, transforming growth factor-beta 4 (TGF-β4), and tumor necrosis factor superfamily-15 (TNF-SF-15) has been documented in the jejunum, liver, spleen, and thymus of naturally infected birds [16]. Despite this robust cytokine activation, viral replication proceeds unchecked, particularly in the gut, indicating that the innate immune response mounted by neonatal chicks is insufficient to control infection, possibly due to the immaturity of the adaptive immune system at hatch [16].

Epidemiologically, WCS exhibits a characteristic pattern in broiler breeder flocks. Affected breeder flocks typically experience a transient drop in egg production, ranging from 0% to 21%, accompanied by a precipitous decline in hatchability of up to 68.4% [18]. This hatchability crisis is concentrated over a two-week period, corresponding to the window of vertical transmission during maternal viremia. Dead-in-shell embryos and chicks too weak to hatch constitute the bulk of losses [24]. Importantly, hatchability typically recovers spontaneously after approximately two weeks, coinciding with the seroconversion of the hen flock. This temporal pattern strongly suggests that maternal antibodies, once generated, effectively block vertical transmission to subsequent progeny [24]. Indeed, breeder flocks with high CAstV-specific ELISA titers produce progeny that are protected from clinical WCS, though virus neutralization (VN) titers in these hens are more variable [25]. This observation has critical implications for vaccine development and the serological monitoring of breeder flocks.

Genetic Determinants of WCS Pathogenicity

The association between specific CAstV genetic lineages and the capacity to induce WCS has been a subject of intense investigation. Phylogenetic analysis of capsid (ORF2) sequences from WCS outbreaks has revealed that virtually all causative strains belong to Group B of CAstV, with a notable predominance of subgroup Biv. In Brazil, WCS-associated isolates have been consistently characterized as subgroup Biv, sharing 95.26% to 99.59% amino acid identity within this subgroup and less than 90% identity with strains from subgroups Bi, Bii, and Biii [9, 16]. Similarly, WCS outbreaks in Western Canada between 2014 and 2019 yielded only Biv strains, with genome sequence analyses revealing evidence of multiple past recombination events in ORF1a, ORF1b, and ORF2 that may have contributed to the emergence of this pathogenic lineage [12]. In Ontario, Canada, however, WCS isolates were classified as subgroup Bii, indicating that the capacity to induce WCS is not exclusive to a single genetic subgroup but is rather a property distributed across multiple Group B clusters [18]. Chinese WCS-associated isolates have been assigned to subgroups Bi, Bii, Biii, Biv, and Bv, as well as a novel B subgroup, demonstrating that the syndrome is caused by a genetically diverse array of CAstV strains [5, 10]. These findings collectively indicate that while WCS is strongly associated with Group B CAstV, the genetic determinants of pathogenicity are likely distributed across multiple loci within the viral genome, potentially involving interactions between the capsid protein, the viral protease (ORF1a), and the RNA-dependent RNA polymerase (ORF1b).

Recombination plays a particularly important role in generating the genetic diversity that underlies WCS pathogenicity. In Canada, recombination detection analyses have identified multiple past recombination events in all three ORFs of Biv strains, with breakpoints that may alter virus-host interactions and tissue tropism [12]. A Chinese Bii recombinant strain, GD202013, was formed from three parental strains, and chicken embryo infection experiments demonstrated that this recombinant caused hatchability reduction, growth depression, and death of embryos with macroscopic lesions in the liver, kidney, and small intestine [7]. The recombination events that generate these pathogenic strains may permit the virus to acquire novel capsid properties that enhance vertical transmission efficiency or increase tropism for the embryonic liver, while maintaining a replication-competent backbone from a second parental strain. This ongoing evolution through recombination poses a significant challenge for vaccine development, as it can rapidly generate antigenically distinct strains that may evade immunity induced by autogenous or experimental vaccines.

Enteric Disease: Runting-Stunting Syndrome and the Spectrum of Intestinal Pathology

While WCS represents a dramatic, vertically transmitted manifestation of CAstV infection, the far more common clinical presentation is that of enteric disease, often classified as runting-stunting syndrome (RSS) or infectious stunting syndrome. RSS is a multifactorial condition of young broiler chicks characterized by poor weight gain, uneven growth, diarrhea, lethargy, and increased feed conversion ratios [6, 17, 31]. The economic impact of RSS is substantial, as affected flocks never achieve their genetic potential for growth, and a significant proportion of birds may be culled due to their failure to thrive. CAstV is now considered one of the primary viral agents associated with RSS, though it frequently acts in concert with other enteric pathogens, including avian nephritis virus (ANV), avian rotavirus, chicken parvovirus, and avian reovirus [1, 22, 23, 37].

The clinical signs of enteric CAstV infection typically manifest within the first week of life. In broiler chicks, the onset of diarrhea occurs at 3 to 6 days post-infection, with affected birds exhibiting pronounced lethargy, apathy, and cloacal pasting [2, 11]. The feces are often watery and may contain undigested feed. At necropsy, the intestines appear pale and thin-walled, filled with yellow or green liquid content and gas [2, 31]. The jejunum, in particular, is the primary site of viral replication, harboring the highest viral loads [2, 16]. Microscopically, the intestinal lesions are characterized by villous atrophy, congestion, and the presence of atrophic cystic glands in the submucosa [29]. These pathological changes disrupt the absorptive surface area of the gut, leading to malabsorption of nutrients and the resulting growth retardation. The liver in enteric cases may show severe congestion and hemorrhages with infiltration of inflammatory cells in the parenchyma, though the necrotic hepatitis typical of WCS is less pronounced [29].

Importantly, CAstV-induced enteric disease does not occur in isolation. Large-scale molecular surveys have demonstrated that CAstV is detected in 38% to 53% of broiler flocks with enteritis, but it is almost invariably found in co-infection with other viruses [1, 22, 23]. In Ecuador, 97% of chickens with enteric disease were positive for at least one enteric virus, with ANV (89%) and CAstV (53%) being the most prevalent; co-infections between CAstV and ANV were particularly common [1]. In Austria, CAstV was detected in 61% of broiler flocks, and the number of enteric viruses detected per flock had a significant negative impact on weight gain and mortality, independent of the presence of clinical diarrhea [23]. These findings underscore the concept that CAstV-associated enteric disease is fundamentally a polymicrobial syndrome, in which the combined effects of multiple viral infections, along with secondary bacterial overgrowth and coccidiosis, determine the severity of clinical outcome. The virus may act as an initiator of intestinal damage, disrupting epithelial integrity and creating an environment permissive for the invasion and proliferation of other pathogens.

Horizontal Transmission and the Role of the Hatchery

The pathogenesis of enteric CAstV disease is intimately linked to the routes of transmission. While WCS is primarily a consequence of vertical transmission from breeder hens to progeny, horizontal transmission via the fecal-oral route is the dominant mechanism for the spread of enteric disease within broiler flocks [6, 24]. The virus is shed in high titers in the feces of infected chicks, and the contaminated environment becomes a persistent source of infection for pen mates. Sentinel birds placed in contact with infected chicks rapidly become infected, developing clinical signs and shedding virus at comparable titers to directly inoculated birds [11]. This efficient horizontal transmission underscores the importance of biosecurity measures, including the use of barn-specific clothing, footbaths, and vermin control, which have been shown to significantly reduce the prevalence of CAstV and other enteric viruses in commercial flocks [23].

The hatchery itself represents a critical node in the transmission dynamics of CAstV. In a longitudinal study of a hatchery-to-farm production chain in Italy, CAstV RNA was detected in chick yolk sacs at 18 days of incubation and in the gut contents of day-old chicks, while environmental samples from the hatchery and the external surfaces of eggs were negative [3]. This pattern strongly suggests that vertical transmission, rather than environmental contamination, is the primary route by which the virus enters the hatchery. The viral load of CAstV was higher in bird tissues at the hatchery stage than at the farm stage, whereas the opposite pattern was observed for ANV [3]. This finding implies that CAstV may be more efficiently transmitted vertically than horizontally, at least in the immediate post-hatch period. The presence of the virus in the yolk sac of 18-day embryos provides a mechanism by which the infection can be established in the developing chick prior to hatch, leading to the systemic dissemination that characterizes both WCS and early-onset enteric disease.

The age of the bird at the time of infection is a critical determinant of disease outcome. Day-old SPF chicks experimentally infected with Malaysian CAstV isolates developed lethargy and diarrhea by 3 days post-infection, with clinical signs beginning to resolve by 6 days post-infection [11]. However, the infected and sentinel-exposed birds exhibited significant growth retardation, with a 20% reduction in body weight persisting at 9 days post-infection. This pattern of acute clinical disease followed by chronic growth impairment is typical of natural RSS outbreaks. The ability of CAstV to cause persistent growth deficits, even after the resolution of diarrhea, points to a mechanism of intestinal damage that extends beyond the acute phase of viral replication. Histopathological examination of the duodenum in experimentally infected chicks revealed mild lymphocytic aggregates, while the kidneys showed tubular degeneration and interstitial nephritis [11]. The renal involvement in enteric CAstV infection is a consistent finding that bridges the gap between the enteric and renal syndromes associated with the virus. It is plausible that the dehydration and electrolyte disturbances resulting from diarrhea exacerbate the renal damage caused by direct viral infection of the kidney, creating a vicious cycle of metabolic derangement and growth failure.

Differential Diagnosis and the Challenge of Polymicrobial Disease

The clinical diagnosis of CAstV-associated enteric disease is confounded by the overlapping presentation of multiple enteric pathogens. Runting-stunting syndrome can be caused by avian reovirus, chicken parvovirus, avian rotavirus, and ANV, either alone or in various combinations [22, 38, 40]. Even in flocks that are positive for CAstV, it is often difficult to attribute the clinical signs solely to this virus, given the high prevalence of coinfections. In a comprehensive molecular survey of 34 Korean broiler flocks with enteritis, 85.3% were positive for at least one enteric virus, and 51.7% of positive flocks harbored two or more viruses [22]. The rank order of detection was ANV (44.1%), CAstV (38.2%), chicken parvovirus (26.5%), IBV (20.6%), avian reovirus (8.8%), and avian rotavirus (5.9%). This pattern of polymicrobial infection has been replicated in studies from Brazil, Austria, Ecuador, and India, confirming that CAstV is rarely the sole enteric pathogen in clinically affected flocks [1, 23, 37, 39].

The challenge of differential diagnosis has driven the development of advanced molecular tools capable of simultaneously detecting multiple enteric viruses. Multiplex RT-qPCR assays targeting CAstV, ANV, IBV, avian rotavirus A, and avian orthoreovirus have demonstrated high sensitivity (limit of detection of 1 copy/μL) and specificity, with no cross-reactivity between targets [1]. These assays are essential for understanding the true prevalence of CAstV in the context of enteric disease and for identifying cases in which CAstV is the dominant or sole pathogen. Such cases are particularly informative for establishing causality. In Brazil, chicks presenting with the “white chick” condition were positive for CAstV in all organs tested, while remaining negative for chicken parvovirus, ANV, avian rotavirus, avian reovirus, IBV, and fowl adenovirus group I [30]. Similarly, in Guangdong province, China, 55.6% of clinical samples from chickens with enteric disease were positive for CAstV but negative for seven other common enteric viruses, suggesting that CAstV was the primary etiological agent in these outbreaks [7]. These data, combined with experimental reproduction of disease in SPF chicks, provide strong evidence that CAstV can act as a primary pathogen capable of inducing enteric disease in the absence of other detectable agents.

The economic impact of CAstV

Diagnostic Methods for Chicken Astrovirus

The accurate and timely diagnosis of Chicken Astrovirus (CAstV) infection is paramount for understanding its epidemiology, implementing control measures, and mitigating the substantial economic losses it inflicts on the global poultry industry. The diagnostic landscape for CAstV has evolved considerably from initial virus isolation and electron microscopy to a sophisticated array of molecular, serological, and advanced genomic techniques. Given the virus's association with a spectrum of clinical manifestations, including runting-stunting syndrome (RSS), severe kidney disease and visceral gout, and the increasingly recognized white chick syndrome (WCS), a multifaceted diagnostic approach is essential [2, 6, 17]. The choice of method is dictated by the objective, whether it be rapid screening of clinical samples, quantification of viral load, serological surveillance of breeder flocks, or high-resolution genotyping for epidemiological investigations. This section provides an exhaustive analysis of the principal diagnostic modalities employed for CAstV detection and characterization.

Molecular Detection: The Cornerstone of Diagnostics

Molecular methods, particularly reverse transcription polymerase chain reaction (RT-PCR) and its quantitative variant (RT-qPCR), have become the gold standard for CAstV detection due to their unparalleled sensitivity, specificity, and speed. The majority of modern diagnostic protocols target conserved regions of the viral genome, most frequently the ORF1b gene, which encodes the RNA-dependent RNA polymerase (RdRp), or the ORF2 gene, which encodes the immunogenic capsid protein [1, 2, 29]. The choice of target is critical; while ORF1b is highly conserved across different CAstV genogroups, providing a robust pan-CAstV detection tool, amplification of the more variable ORF2 allows for subsequent genotyping and phylogenetic classification into subgroups Ai, Aii, Bi, Bii, Biii, Biv, Bv, and Bvi [5, 9, 20].

Quantitative RT-PCR (RT-qPCR)

The development of RT-qPCR assays has revolutionized CAstV diagnostics by enabling not only detection but also precise quantification of viral genome copies. This capability is crucial for understanding viral pathogenesis, monitoring the dynamics of infection, and evaluating the efficacy of intervention strategies such as vaccination. Two primary chemistries dominate this field: SYBR® Green-based assays and the more specific hydrolysis probe-based (e.g., TaqMan) assays.

A fast SYBR® Green RT-qPCR assay has been validated for the detection of CAstV in chicks with enteric disease, demonstrating high efficiency (97.3%) and a limit of detection (LoD) and quantification (LoQ) of 101 viral gene copies per reaction [2]. This assay’s melting curve analysis produced a single specific peak at a melting temperature (Tm) of 77.5 °C, confirming the specificity of amplification and ruling out non-specific products or primer-dimers [2]. The SYBR Green approach offers a cost-effective solution, particularly valuable for large-scale screening in resource-limited settings.

Conversely, multiplex RT-qPCR assays, which employ sequence-specific hydrolysis probes labeled with distinct fluorophores, allow for the simultaneous detection and differentiation of CAstV from a panel of other enteric pathogens. A highly cited study validated a multiplex RT-qPCR assay capable of detecting CAstV alongside avian nephritis virus (ANV), infectious bronchitis virus (IBV), avian rotavirus A (AvRVA), and avian orthoreovirus (ARV) in a single reaction [1]. This assay displayed exceptional performance characteristics, with amplification efficiencies between 98.8% and 105.9% and a detection limit down to a single copy per microliter (1 copy/μL) for each target [1]. Crucially, it exhibited no cross-reactivity among the five viruses, a feat achieved through rigorous primer and probe design. The ability to simultaneously detect CAstV in the context of frequent co-infections, with prevalence rates of up to 53% in some studies, often in concert with ANV [1, 22, 37], makes multiplexing an indispensable tool for clinical diagnostics and research. Another study utilized RT-qPCR to trace viral dynamics from hatchery to farm, revealing higher CAstV copy numbers in bird tissues from the hatchery compared to later farm stages, suggesting a heavy vertical transmission component [3]. Furthermore, RT-qPCR has been instrumental in quantifying viral loads in various tissues (e.g., proventriculus, liver, kidney, duodenum, pancreas) following experimental infection, demonstrating that the highest viral loads are often found in the proventriculus and kidney, correlating with specific pathological lesions [27].

Conventional RT-PCR

Despite the advantages of qPCR, conventional endpoint RT-PCR remains a widely used and reliable method, particularly for initial detection and for generating amplicons for downstream sequencing. It has been employed successfully in numerous epidemiological surveys worldwide, including the first detection of CAstV in Kerala, India, where 5 out of 50 broiler flocks with clinical signs were positive using primers targeting the partial ORF1b gene [34]. Similarly, RT-PCR has been used to confirm CAstV in clinical samples from hatcheries in Nigeria, identifying the virus in 83.5% of condemned or runted day-old turkey poults [13]. The technique is also essential for confirming the presence of CAstV in pooled intestinal samples from flocks with a history of enteritis [29, 37]. While less precise for quantification than RT-qPCR, conventional RT-PCR remains a stalwart for molecular epidemiology due to its simplicity and lower equipment costs.

Virus Isolation and Propagation: The Traditional Gold Standard

While molecular tests are now primary, virus isolation in biological systems remains critical for obtaining live virus for antigenic characterization, vaccine development, and detailed pathogenicity studies. Two main systems are used for CAstV isolation: specific-pathogen-free (SPF) embryonated chicken eggs (ECE) and continuous cell lines.

Isolation in Embryonated Chicken Eggs (ECE)

The yolk sac route of inoculation in 5- to 14-day-old SPF ECEs is a well-established and successful method for primary CAstV isolation [8, 15, 34, 42]. Following incubation, characteristic lesions are observed, including embryo dwarfing or stunting, hemorrhages, edema, and a gelatinous appearance [8, 42]. This method has been critical in isolating novel strains, such as the Malaysian isolates which were grouped into a new subgroup, Bv, and the first CAstV isolates from Bangladesh [11, 15]. However, the method is labor-intensive, time-consuming (requiring multiple passages), and ethically sensitive. Recent studies have effectively utilized this technique to study pathogenicity, demonstrating that CAstV isolates can cause a 100% mortality rate in chicken embryos when inoculated at high titers, with lesions including urate deposits on the epicardium, kidney, and necrotic spots on the liver [10]. The ECE system is particularly effective for isolating vertically transmitted strains associated with hatchery diseases like WCS, as demonstrated by the recovery of CAstV from the yolk sacs of 18-day-old incubated eggs [3].

Isolation in Cell Culture

Continuous cell lines, most notably the Leghorn male hepatoma (LMH) cell line, have proven to be a robust system for CAstV isolation and propagation [7, 35, 41]. The LMH cell line supports the replication of various CAstV strains, inducing a recognizable cytopathic effect (CPE). For instance, the Chinese isolate NJ1701 was successfully propagated in LMH cells, as was the GD202013 strain [7, 35]. More recently, the DF-1 chicken fibroblast cell line has been successfully used for the growth of goose astrovirus (GAstV), demonstrating the broad utility of cell culture systems for avian astroviruses [44]. The ability to grow CAstV in cell culture is a prerequisite for plaque assays, virus neutralization (VN) tests, and the production of inactivated vaccines, such as the Biv-inactivated oil emulsion vaccine used to stimulate antibody production in SPF leghorns [25]. The success of isolation in cell culture can be confirmed by indirect immunofluorescence assay (IFA) or electron microscopy [33, 43].

Serological and Immunological Methods

Serological assays are essential for monitoring the immune status of breeder flocks, evaluating vaccine responses, and conducting large-scale seroprevalence studies. The two primary formats are the enzyme-linked immunosorbent assay (ELISA) and the virus neutralization (VN) test.

Enzyme-Linked Immunosorbent Assay (ELISA)

Commercial CAstV ELISA kits are available and are widely used for surveillance, providing a high-throughput means of detecting antibodies in serum. A study in Grenada used a commercial ELISA to report a seroprevalence of 57.6% in commercial layers and 61.5% in indigenous chickens [36]. In Malaysia, ELISA results revealed a high prevalence of antibodies against CAstV among broiler breeder flocks, confirming widespread exposure [8]. While convenient, ELISA titers do not always correlate perfectly with protective immunity. In one study, serum from breeder flocks whose progeny suffered from WCS had consistently high ELISA titers, yet these birds were clearly not protective against vertical transmission [25]. This suggests ELISA may detect binding antibodies that are not necessarily functional in neutralizing the virus. Furthermore, some ELISA kits may lack the breadth to detect antibodies against divergent CAstV subgroups, as evidenced by the failure of a commercial ELISA to detect seroconversion in SPF birds vaccinated with a Biv-inactivated vaccine, despite clear evidence of neutralizing antibodies [25].

Virus Neutralization (VN) Assay

The VN assay is considered the gold standard for evaluating functional, protective antibody responses. Unlike ELISA, VN measures the ability of antibodies to prevent viral infection in a cell culture model. For CAstV, a VN test using the homologous or a genetically similar viral strain as the antigen is the preferred method for monitoring vaccinated flocks [25]. In the same study where ELISA failed, the VN test successfully detected seroconversion in vaccinated birds from 8 weeks post-initial vaccination onward, and the VN titers were positively correlated with the vaccine dose [25]. The VN test is also crucial for characterizing the antigenic differences between CAstV subgroups and for assessing the potential cross-protection offered by vaccines against heterologous field strains. However, VN assays are more labor-intensive, require access to cell culture facilities and live virus, and are less amenable to high-throughput automation compared to ELISA, limiting their use to specialized research and reference laboratories.

Advanced Molecular Characterization and Genotyping

Beyond simple detection, detailed genetic characterization of CAstV is vital for tracking viral evolution, identifying new variants, and understanding the molecular basis of pathogenicity and tissue tropism. This is achieved primarily through nucleotide sequencing and phylogenetic analysis.

Sequencing and Phylogenetic Analysis

Sequencing of the ORF2 gene, or the entire genome, has revealed extensive genetic diversity, leading to the current classification of CAstV into two genogroups (A and B) with multiple subgroups [5, 20, 21]. Phylogenetic analysis based on the complete ORF2 amino acid sequence is the standard for assigning a new isolate to a specific subgroup. For example, a study of 31 CAstV isolates in China identified isolates belonging to subgroups Ai, Bi, Bii, Biii, Biv, Bv, and a proposed new B subgroup, demonstrating the high degree of diversity even within a single country [5]. Similarly, sequencing of ORF2 from Brazilian isolates confirmed that WCS-associated strains belonged to subgroup Biv [9]. Whole-genome sequencing provides an even higher resolution, enabling the detection of recombination events, which appear to be a major driver of CAstV evolution. A Canadian study analyzing 14 whole-genome sequences from WCS outbreaks provided definitive evidence of multiple historic recombination events within the ORF1a, ORF1b, and ORF2 genes [12].

Next-Generation Sequencing (NGS) and Metagenomics

The advent of next-generation sequencing (NGS) has transformed CAstV genomics. NGS allows for the rapid and comprehensive sequencing of the entire viral genome directly from clinical samples without the need for prior virus isolation. This approach has been instrumental in characterizing the first Italian full-length genome of ANV and in assembling near-complete CAstV genomes from clinical samples in Poland and India [3, 19, 21]. NGS is uniquely powerful in a metagenomic context, allowing for the simultaneous detection and characterization of CAstV alongside the entire virome of a clinical sample. For instance, a metagenomic study of chicken clinical samples from Belgium successfully assembled a complete IBV genome and a near-complete CAstV genome from the same sample, along with reads from other viruses such as chicken calicivirus and avian leucosis virus [45]. This unbiased approach is invaluable for investigating complex enteric disease, especially when co-infections are suspected.

Ancillary and Rapid Diagnostic Methods

While molecular and classical virological methods dominate, other techniques serve specific roles. Transmission electron microscopy (TEM) can be used for direct visualization of astrovirus particles in clinical samples, revealing their characteristic 28-30 nm, non-enveloped, stellate morphology [13, 42]. However, TEM requires high viral concentrations and specialized expertise, making it unsuitable for routine diagnosis but valuable for research. Histopathology is not a primary diagnostic method for CAstV itself but is crucial for assessing its pathological impact. Characteristic lesions include villous atrophy in the intestine, interstitial nephritis and tubular degeneration in the kidney, necrotic hepatitis, and lymphocytic inflammation in the proventriculus and pancreas [11, 16, 27, 29]. Real-time RT-PCR remains the most rapid and sensitive method for detection, though newer isothermal amplification technologies (e.g., LAMP) are being explored for point-of-care applications, even though they have not yet been widely adopted for CAstV in published literature. The need for rapid, field-deployable diagnostics is underscored by the significant economic impact of the virus, which is classified as an important pathogen by organizations such as the World Organisation for Animal Health (WOAH) due to its effects on poultry productivity and trade.

Vaccination and Immune Response

The development of effective vaccination strategies against chicken astrovirus (CAstV) remains one of the most pressing challenges in contemporary avian medicine, yet it is a domain fraught with immunological complexities, diagnostic ambiguities, and a conspicuous absence of commercially licensed products. Unlike the well-established vaccine regimens for pathogens such as infectious bronchitis virus (IBV) or Newcastle disease virus, the path to immunoprophylaxis for CAstV is obstructed by profound genetic diversity, the intricacies of vertical transmission, and a still-nascent understanding of the correlates of protective immunity. The immune response to CAstV, whether elicited by natural infection or experimental vaccination, is a multifaceted interplay between humoral and cellular arms, modulated by viral evasion strategies and the unique immunological landscape of the neonatal chick. A deep analysis of the available literature reveals that while significant strides have been made in characterizing antibody responses and developing prototype vaccines, the field is grappling with fundamental questions regarding antigenic targets, the reliability of serological monitoring, and the induction of sterilizing immunity at mucosal surfaces.

The Humoral Response: A Tale of Two Serological Assays

The cornerstone of adaptive immunity to CAstV is the production of virus-specific antibodies, yet the detection and interpretation of these antibodies are profoundly dependent on the assay employed. This dichotomy is most starkly illustrated in the context of vaccination trials. A landmark study by Sousa et al. [25] evaluating an inactivated, oil-emulsion CAstV vaccine (group Biv) in specific-pathogen-free (SPF) leghorns revealed a critical disconnect between two common serological tools. Following a two-dose regimen at 3 and 9 weeks of age, serum samples collected at 8, 10, 12, and 14 weeks post-initial vaccination were uniformly negative for CAstV-specific antibodies when tested using a commercial enzyme-linked immunosorbent assay (ELISA). However, the same sera demonstrated unequivocal seroconversion when analyzed by a virus neutralization (VN) assay using a genetically homologous CAstV isolate [25]. This finding is not merely a technical nuance; it has profound implications for vaccine evaluation and field surveillance. The commercial ELISA, likely designed against a broader or different antigenic spectrum, failed to recognize antibodies elicited by a specific subgroup Biv strain. Conversely, the VN assay, which measures functional antibodies capable of blocking viral entry, proved exquisitely sensitive and specific for the vaccine strain. This suggests that the humoral response, particularly in vaccinated birds, may be highly strain-specific, targeting conformational epitopes on the capsid protein that are not adequately represented in a standard ELISA format. The study further noted that serum from naturally infected breeder flocks with a history of white chick syndrome (WCS) had consistently high ELISA titers, but their VN titers were more variable [25]. This implies that natural infection, with its continuous antigenic stimulation and potential for exposure to multiple strains, may generate a broader, more cross-reactive antibody repertoire that is more readily captured by ELISA, whereas vaccination with a single inactivated strain induces a narrower, functionally potent but serologically "hidden" response.

This strain-specificity of the humoral response is a direct consequence of the extreme genetic variability of the CAstV capsid protein, encoded by ORF2. Phylogenetic analyses have delineated two major genogroups (A and B), with group B further subdivided into at least six subgroups (Bi through Bvi), where inter-subgroup amino acid identity in the capsid can be as low as 82% [20, 48]. The capsid protein, particularly the spike domain, is the primary target for neutralizing antibodies [9]. Therefore, a vaccine based on a Biv strain, as used by Sousa et al. [25], may elicit antibodies that fail to recognize or neutralize a Bii or Biii strain. This antigenic divergence is a formidable barrier to developing a "universal" CAstV vaccine. The identification of 14 highly conserved antigenic peptides on the surface of the capsid protein from Brazilian Biv strains offers a potential avenue for overcoming this, suggesting that a subunit or epitope-based vaccine targeting these conserved regions could theoretically induce broader protection [9]. However, the immunodominance of variable regions may still skew the response away from these conserved epitopes.

Cellular Immunity and the Cytokine Milieu

While humoral immunity is critical for neutralizing extracellular virus and preventing infection, cellular immunity, mediated by T lymphocytes and their cytokine products, is essential for controlling viral replication within infected cells and orchestrating the overall immune response. The innate and adaptive cellular responses to CAstV are poorly understood, but pioneering work by Nuñez et al. [16] on naturally infected WCS chicks has begun to illuminate the cytokine storm that characterizes early infection. In day-old chicks, CAstV infection triggered a significant upregulation of both Th1 (IFN-γ, IL-2, IL-12p40, t-BET) and Th2 (TGF-β4) associated cytokines in the jejunum, liver, spleen, and thymus [16]. The activation of IFN-γ, a master regulator of antiviral immunity, suggests a robust attempt by the host to mount a cell-mediated response. However, the study paradoxically found that this cytokine activation was insufficient to control viral replication, as evidenced by high viral loads in the gut [16]. This may be due to the immunological immaturity of the neonatal chick, whose adaptive immune system is not fully functional, or it may reflect active viral immune evasion strategies.

One such evasion mechanism has recently been elucidated: the hijacking of host cellular protein Musashi homolog 1 (MSI1). Zhou et al. [28] demonstrated that CAstV, along with other plus-strand RNA viruses, upregulates MSI1 expression and facilitates its translocation to the nucleus. This hijacking event serves to shield viral RNA from degradation by cytoplasmic ribonucleases, thereby promoting viral replication and persistence [28]. By subverting this fundamental host defense, CAstV can effectively dampen the efficacy of the early innate immune response and delay the activation of a fully effective adaptive cellular response. This finding underscores the need for vaccines that can rapidly induce a potent, multi-pronged immune response capable of overcoming such viral countermeasures.

Vaccine Strategies: From Autogenous to Recombinant

In the absence of a commercial vaccine, the poultry industry has resorted to autogenous vaccines (AVs), which are custom-made from farm-specific isolates. The study by Sousa et al. [25] provides the first validated data on the immunogenicity of such an approach. The inactivated, adjuvanted AV successfully induced neutralizing antibodies, as measured by VN, but failed to produce a detectable ELISA response. This highlights a critical practical challenge: monitoring vaccine take in the field. If ELISA is the only tool available, a veterinarian might incorrectly conclude that the vaccine is ineffective. The study advocates for the use of VN serology with a genetically similar CAstV antigen as the preferred method for monitoring seroconversion in vaccinated flocks [25]. However, VN assays are more labor-intensive, time-consuming, and expensive than ELISAs, limiting their widespread application. Furthermore, the ultimate proof of efficacy for any WCS vaccine, prevention of vertical transmission and protection of progeny, remains elusive, as there is no established and reproducible challenge model for WCS [25]. The observation that hatchability is typically restored in breeder flocks approximately two weeks after natural seroconversion [24] provides a strong rationale for vaccination, but it also suggests that a robust and sustained humoral response in the hen is the key correlate of protection for the embryo.

A more sophisticated and promising approach is the use of recombinant vector vaccines. Meng et al. [47] developed a recombinant human adenovirus type 5 (HAdV-5) vector expressing the CAstV ORF2 capsid protein (rAd5-CAstV-ORF2). This platform offers several immunological advantages over traditional inactivated vaccines. First, it targets the mucosal immune system, which is the primary portal of entry for CAstV via the fecal-oral route. The HAdV-5 vector is highly efficient at transducing mucosal epithelial cells and presenting the antigen to the gut-associated lymphoid tissue (GALT). Second, it induces a balanced immune response. In SPF chickens, immunization with rAd5-CAstV-ORF2 elicited strong humoral immunity, with serum antibody titers reaching 1:2000 to 1:3000 by day 21 post-vaccination [47]. More importantly, it induced potent cellular immunity, characterized by a significant 3.5-fold increase in IFN-γ (a Th1 cytokine) and production of IL-4 (a Th2 cytokine) [47]. This dual Th1/Th2 response is crucial for both neutralizing extracellular virus and eliminating infected cells. The vaccine also demonstrated significant protection in a challenge model: vaccinated birds had markedly reduced clinical scores, mitigated growth retardation, and a substantial 1.0 to 3.0 log reduction in viral loads in tissues, indicating effective inhibition of viral replication and shedding [47]. Histopathological analysis confirmed reduced damage to target organs like the kidneys, liver, and duodenum [47]. This study validates the HAdV-5 platform as a powerful tool for inducing mucosal immunity against enteric avian pathogens and provides a clear roadmap for a next-generation CAstV vaccine.

Parallel developments in related astroviruses, such as goose astrovirus (GAstV), offer additional insights. The use of egg yolk antibodies (IgY) from hyperimmunized hens has proven effective for passive immunization against GAstV, reducing symptoms, mortality, and viral load in goslings [46]. This strategy could be adapted for CAstV, providing immediate passive protection to hatchlings via maternal antibody transfer or direct administration, particularly in the face of an outbreak. Furthermore, the use of viral vectors like duck enteritis virus (DEV) to deliver the GAstV capsid protein [43] demonstrates the feasibility of bivalent vaccines that could simultaneously protect against multiple avian pathogens, a concept directly applicable to CAstV.

The Challenge of Co-infections and Immunomodulation

The immune response to CAstV does not occur in a vacuum. Epidemiological studies consistently demonstrate that CAstV is frequently found in co-infections with other enteric viruses, including avian nephritis virus (ANV), avian rotavirus, and chicken parvovirus [1, 3, 22, 23]. The immunological consequences of these co-infections are poorly understood but are likely profound. Concurrent infections could lead to immune dysregulation, where the host's response to one pathogen is altered by the presence of another. For instance, a co-infection might suppress the IFN-γ response to CAstV, exacerbating disease, or it could lead to antigenic competition, blunting the vaccine response. The high prevalence of co-infections, with up to five different enteric viruses detected in a single flock [23], underscores the complexity of the enteric disease syndrome and the need for vaccination strategies that can provide broad protection or be integrated into comprehensive health management programs. The significant economic impact of these viral loads, even in the absence of clinical diarrhea [23], further emphasizes that any successful vaccine must not only prevent disease but also reduce viral shedding to break the cycle of transmission.

References

[1] Loor-Giler A, Muslin C, Santander-Parra S, Coello D, Robayo-Chico M, Ferreira AP, et al.. Simultaneous detection and partial molecular characterization of five RNA viruses associated with enteric disease in chickens: chicken astrovirus, avian nephritis virus, infectious bronchitis virus, avian rotavirus a and avian orthoreovirus, via multiplex RT–qPCR. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1536420

[2] Santander-Parra S, Astolfi-Ferreira C, Loor-Giler A, Kyriakidis N, Ferreira AP, Nuñez LFN. First report of molecular detection of chicken astrovirus (CAstV) in chicks affected with enteric disease in Ecuador through a fast RT-qPCR assay based on SYBR® Green. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04578-2

[3] Grego E, Bertolotti L, Colitti B, Stella MC, Catania AM, Castellina C. Detection and genetic characterization of chicken astrovirus and avian nephritis virus from hatchery to farm. Avian Pathology. 2024. DOI: https://doi.org/10.1080/03079457.2024.2365249

[4] Kariithi H, Volkening J, Chiwanga G, Pantin-Jackwood M, Msoffe P, Suarez D. Genome Sequences and Characterization of Chicken Astrovirus and Avian Nephritis Virus from Tanzanian Live Bird Markets. Viruses. 2023. DOI: https://doi.org/10.3390/v15061247

[5] Han X, Yin L, Liang X, Liang H. Molecular characterization of chicken astrovirus and pathogenicity of a novel isolate in China. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1280313

[6] Raji A, Omar A. Pathogenesis of Chicken Astrovirus Related Illnesses. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.899901

[7] Yin L, Zhou Q, Mai K, Huang J, Yan Z, Wei X, et al.. Isolation and characterization of a novel chicken astrovirus in China. Poultry Science. 2021. DOI: https://doi.org/10.1016/j.psj.2021.101363

[8] Raji AA, Ideris A, Bejo M, Omar A. Molecular Detection, Characterisation and Serological Survey of Chicken Astrovirus from Broiler Flocks in Malaysia. Pertanika journal of science & technology. 2022. DOI: https://doi.org/10.47836/pjst.30.2.43

[9] Torre DIDl, Astolfi-Ferreira C, Chacón RD, Ferreira AJP. Molecular characterization of chicken astrovirus from high embryonic mortality, based on the capsid protein (ORF2) gene, in Brazil. Avian Pathology. 2022. DOI: https://doi.org/10.1080/03079457.2022.2098691

[10] Luan Q, Han Y, Yin Y, Wang J. Genetic diversity and pathogenicity of novel chicken astrovirus in China. Avian Pathology. 2022. DOI: https://doi.org/10.1080/03079457.2022.2102966

[11] Raji A, Ideris A, Bejo M, Omar A. Molecular characterization and pathogenicity of novel Malaysian chicken astrovirus isolates. Avian Pathology. 2021. DOI: https://doi.org/10.1080/03079457.2021.2000939

[12] Palomino-Tapia VA, Mitevski D, Inglis T, Meer Fvd, Martin E, Brash M, et al.. Chicken Astrovirus (CAstV) Molecular Studies Reveal Evidence of Multiple Past Recombination Events in Sequences Originated from Clinical Samples of White Chick Syndrome (WCS) in Western Canada. Viruses. 2020. DOI: https://doi.org/10.3390/v12101096

[13] Adebiyi A, McIlwaine K, Oluwayelu D, Smyth V. Detection and characterization of chicken astrovirus associated with hatchery disease in commercial day-old turkeys in southwestern Nigeria. Archives of Virology. 2021. DOI: https://doi.org/10.1007/s00705-021-05034-w

[14] Mase M, Hiramatsu K, Watanabe S, Tanikawa T. The enteric virus associated with baby chick nephropathy in Japan was genetically identified as chicken astrovirus, not avian nephritis virus. Journal of Veterinary Medical Science. 2026. DOI: https://doi.org/10.1292/jvms.25-0545

[15] Ali MZ, Moula MM, Bhuiyan ZA, Giasuddin M, Shin H. First Isolation and Molecular Characterization of Chicken Astrovirus and Avian Nephritis Virus in Chickens in Bangladesh. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.769489

[16] Nuñez LFN, Santander-Parra S, Kyriakidis NC, Astolfi-Ferreira C, Buim M, Torre DIDl, et al.. Molecular Characterization and Determination of Relative Cytokine Expression in Naturally Infected Day-Old Chicks with Chicken Astrovirus Associated to White Chick Syndrome. Animals. 2020. DOI: https://doi.org/10.3390/ani10071195

[17] Smyth V. A Review of the Strain Diversity and Pathogenesis of Chicken Astrovirus. Viruses. 2017. DOI: https://doi.org/10.3390/v9020029

[18] Long K, Ouckama R, Weisz A, Brash M, Ojkić D. White Chick Syndrome Associated with Chicken Astrovirus in Ontario, Canada. Avian diseases. 2018. DOI: https://doi.org/10.1637/11802-012018-Case.1

[19] Patel AK, Pandit R, Thakkar JR, Hinsu A, Pandey VC, Pal JK, et al.. Complete genome sequence analysis of chicken astrovirus isolate from India. Veterinary research communications. 2016. DOI: https://doi.org/10.1007/s11259-016-9673-6

[20] Raji A, Omar A. An Insight into the Molecular Characteristics and Associated Pathology of Chicken Astroviruses. Viruses. 2022. DOI: https://doi.org/10.3390/v14040722

[21] Sajewicz-Krukowska J, Domańska-Blicharz K. Nearly full-length genome sequence of a novel astrovirus isolated from chickens with ‘white chicks’ condition. Archives of Virology. 2016. DOI: https://doi.org/10.1007/s00705-016-2940-6

[22] Koo B, Lee H, Jeon E, Han M, Min K, Lee S, et al.. Molecular survey of enteric viruses in commercial chicken farms in Korea with a history of enteritis. Poultry Science. 2013. DOI: https://doi.org/10.3382/ps.2013-03280

[23] Grafl B, Gaußmann B, Bilic I, Folkertsma R, Hess M. Influence of biosecurity on the occurrence of various enteric viruses in broiler flocks. Avian Pathology. 2024. DOI: https://doi.org/10.1080/03079457.2024.2377337

[24] McIlwaine K, Law CJ, Lemon K, Grant I, Smyth V. A Review of the Emerging White Chick Hatchery Disease. Viruses. 2021. DOI: https://doi.org/10.3390/v13122435

[25] Sousa J, Nicholds JA, Linnemann E, Gilbert R, Allen T, Taylor C, et al.. Antibody Response in Pullets Vaccinated with Inactivated Chicken Astrovirus for White Chick Syndrome.. Avian diseases. 2025. DOI: https://doi.org/10.1637/aviandiseases-d-25-00036

[26] Sajewicz-Krukowska J, Mirosław P, Jastrzębski J, Domańska-Blicharz K, Tarasiuk K, Marzec-Kotarska B. miRNA Expression Signatures Induced by Chicken Astrovirus Infection in Chickens. International Journal of Molecular Sciences. 2023. DOI: https://doi.org/10.3390/ijms242015128

[27] Bi X, Song Z, Meng F, Sun S, Du X, Yang M, et al.. Molecular characteristics and pathogenicity of a novel chicken astrovirus variant. Veterinary Research. 2023. DOI: https://doi.org/10.1186/s13567-023-01250-1

[28] Zhou D, Xu M, Liu Q, Xin R, Cui G, Ding L, et al.. Plus-strand RNA viruses hijack Musashi homolog 1 to shield viral RNA from cytoplasmic ribonuclease degradation. Journal of Virology. 2025. DOI: https://doi.org/10.1128/jvi.00023-25

[29] Patidar C, Sharma D, Singathia R, Suthar P, Saraswat A, Singh G, et al.. Molecular Detection and Phylogenetic Analysis of Chicken Astrovirus Associated with Poultry Enteritis. Indian Journal of Animal Research. 2021. DOI: https://doi.org/10.18805/ijar.b-4526

[30] Nuñez L, Parra SHS, Carranza C, Astolfi-Ferreira C, Buim M, Ferreira A. Detection and molecular characterization of chicken astrovirus associated with chicks that have an unusual condition known as “white chicks” in Brazil. Poultry Science. 2016. DOI: https://doi.org/10.3382/ps/pew062

[31] Koo B, Lee H, Jeon E, Jang H, Han M, Mo I. An unusual case of concomitant infection with chicken astrovirus and group A avian rotavirus in broilers with a history of severe clinical signs. Journal of Veterinary Sciences. 2013. DOI: https://doi.org/10.4142/jvs.2013.14.2.231

[32] Li L, Sun M, Zhang Y, Liao M. A Review of the Emerging Poultry Visceral Gout Disease Linked to Avian Astrovirus Infection. International Journal of Molecular Sciences. 2022. DOI: https://doi.org/10.3390/ijms231810429

[33] Zhu Y, Wang H, Hua J, Ye W, Chen L, Ni Z, et al.. Isolation and Pathogenicity of a Novel Goose Astrovirus from Overfed Adult Landaise Geese in China. Viruses. 2022. DOI: https://doi.org/10.3390/v14122806

[34] Sarma S, R R, Ravishankar C, K. S, M P, R A, et al.. Molecular Detection and Isolation of Chicken Astrovirus from Commercial Chicken Flocks of Kerala, India. Asian journal of microbiology and biotechnology. 2024. DOI: https://doi.org/10.56557/ajmab/2024/v9i28921

[35] Zhao W, Wu Z, Yao Y, Qin A, Qian K. The Isolation and Molecular Characterization of an Astrovirus From “Yellow” Chickens, China. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/fvets.2020.581862

[36] Sharma R, Dufayet R, Maufras T, Connell KO, Tiwari K. Seroprevalence of antibodies to astrovirus in chickens in Grenada, West Indies. Veterinary World. 2017. DOI: https://doi.org/10.14202/vetworld.2017.636-639

[37] Torre DIDl, Nuñez L, Astolfi-Ferreira C, Ferreira AJP. Enteric Virus Diversity Examined by Molecular Methods in Brazilian Poultry Flocks. Veterinary Sciences. 2018. DOI: https://doi.org/10.3390/vetsci5020038

[38] Pradeep M, Reddy MR, Kannaki T. Molecular Identification and Characterization of Chicken Parvovirus from Indian Chicken and Association with Runting and Stunting Syndrome. Indian Journal of Animal Research. 2020. DOI: https://doi.org/10.18805/ijar.b-3890

[39] Thachamvally R, Chander Y, Kumar R, Kumar G, Khandelwal N, G. A, et al.. First Isolation and Genetic Characterization of Avian Nephritis Virus 4 from Commercial Poultry in India. Avian diseases. 2024. DOI: https://doi.org/10.1637/aviandiseases-D-23-00053

[40] Mettifogo E, Nuñez L, Chacón J, Parra SSS, Astolfi-Ferreira C, Jerez JA, et al.. Emergence of Enteric Viruses in Production Chickens Is a Concern for Avian Health. TheScientificWorldJournal. 2014. DOI: https://doi.org/10.1155/2014/450423

[41] Zhao W, Shi J, Yao Y, Shao H, Qin A, Qian K. Isolation, Identification, and Genomic Characterization of Chicken Astrovirus Isolates From China. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2021.800649

[42] Nuñez L, Parra SHS, Mettifogo E, Catroxo M, Astolfi-Ferreira C, Ferreira AJP. Isolation of chicken astrovirus from specific pathogen-free chicken embryonated eggs.. Poultry Science. 2015. DOI: https://doi.org/10.3382/ps/pev086

[43] Chen L, Zhu Y, Yun T, Ye W, Ni Z, Hua J, et al.. In vitro expression of the goose astrovirus Cap protein delivered with a duck enteritis virus vector. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04654-7

[44] Li J, Hu W, Liu T, Zhang H, Opriessnig T, Xiao C. Isolation and evolutionary analyses of gout-associated goose astrovirus causing disease in experimentally infected chickens. Poultry Science. 2020. DOI: https://doi.org/10.1016/j.psj.2020.11.003

[45] Borm Sv, Steensels M, Mathijs E, Vandenbussche F, Berg TPvd, Lambrecht B. Metagenomic sequencing determines complete infectious bronchitis virus (avian Gammacoronavirus) vaccine strain genomes and associated viromes in chicken clinical samples. Virus genes. 2021. DOI: https://doi.org/10.1007/s11262-021-01872-7

[46] Xu P, Lu J, Chen L, Chen X, Lu Z, Ye M, et al.. Development of a chicken egg yolk antibody (IgY) could effectively prevent and treat goose astrovirus infection.. Vaccine. 2025. DOI: https://doi.org/10.1016/j.vaccine.2025.127167

[47] Meng F, Li R, Ding L, Wang Z, Liu X, Song Y, et al.. A recombinant adenoviral vector vaccine expressing the ORF2 capsid protein confers robust protection against chicken astrovirus infection. Veterinary Research. 2026. DOI: https://doi.org/10.1186/s13567-025-01667-w

[48] Tan Z, Zhai H, Sun R, Sun Z, Xie R, Zhang L, et al.. Complete genome sequence and phylogenetic analysis of a goose astrovirus isolate in China. Brazilian Journal of Microbiology. 2022. DOI: https://doi.org/10.1007/s42770-022-00854-7